Skip to main content
SpringerLink
Log in

Endobrachyœsophage (EBO): surveillance et indications thérapeutiques

Barrett’s esophagus: monitoring and therapeutic indications

  • Formation Médicale Continue / Continuing Medical Education
  • Published:
Acta Endoscopica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s esophagus. Gut 2007;56:763–771.

    Article  PubMed  CAS  Google Scholar 

  2. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670–1677.

    Article  PubMed  Google Scholar 

  3. Ward EM, Wolfsen HC, Achem SR, Loeb DS, Krishna M, Hemminger LL, et al. Barrett’s esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 2006;101:12–17.

    Article  PubMed  Google Scholar 

  4. Steevens J, Schouten LJ, Driessen AL, Huysentruyt CJ, Keulemans YC, Goldbohm RA, et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 2011;20:345–358.

    Article  PubMed  Google Scholar 

  5. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392–1399.

    Article  PubMed  Google Scholar 

  6. Curvers WL, Bansal A, Sharma P, Bergman JJ. Endoscopic workup of early Barrett’s neoplasia. Endoscopy 2008;40:1000–1007.

    Article  PubMed  CAS  Google Scholar 

  7. Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr. Methylene blue selectively stains intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 1996;44:1–7.

    Article  PubMed  CAS  Google Scholar 

  8. Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s esophagus. Lancet 2003;362:373–374.

    Article  PubMed  CAS  Google Scholar 

  9. Sharma P, Weston AP, Topalovski M, Cherian R, Bhattacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gut 2003;52:24–27.

    Article  PubMed  CAS  Google Scholar 

  10. Sharma P, Marcon N, Wani S, Bansal A, Mathur S, Sampliner R, et al. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett’s esophagus: a prospective multicenter study. Endoscopy 2006;38:1206–1212.

    Article  PubMed  CAS  Google Scholar 

  11. Wolfsen HC, Crook JE, Krishna M, Achem SR, Devault KR, Bouras EP. Prospective, controlled tandem endoscopy study of narrow-band imaging for dysplasia detection in Barrett’s esophagus. Gastroenterology 2008;135:24–31.

    Article  PubMed  Google Scholar 

  12. Kara MA, Ennahachi M, Fockens P, Ten Kate FJ, Bergman JJ. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett’s esophagus by using narrow band imaging. Gastrointest Endosc 2006;64:155–166.

    Article  PubMed  Google Scholar 

  13. Pohl J, May A, Rabenstein T, Pech O, Nguyen-Tat M, Fissler-Eckhoff A, et al. Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett’s esophagus. Endoscopy 2007;39:594–598.

    Article  PubMed  CAS  Google Scholar 

  14. Curvers W, Baak L, Kiesslich R, van Oijen A, Rabenstein T, Ragunath K, et al. Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett’s esophagus. Gastroenterology 2008;134:670–679.

    Article  PubMed  Google Scholar 

  15. Sharma P, Meining AR, Coron E, Lightdale CJ, Wolfsen HC, Bansal A, et al. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011;74:465–472.

    Article  PubMed  Google Scholar 

  16. Gordon V, Jankowski J. Chemoprevention in Barrett’s esophagus. Best Pract Res Clin Gastroenterol 2011;25:569–579.

    Article  PubMed  CAS  Google Scholar 

  17. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and metaanalysis. Am J Epidemiol 2008;168:237–249.

    Article  PubMed  Google Scholar 

  18. Gatenby P, Ramus J, Caygill C, Shepherd N, Winslet M, Watson A. Routinely diagnosed low-grade dysplasia in Barrett’s esophagus: a population-based study of natural history. Histopathology 2009;54:814–819.

    Article  PubMed  Google Scholar 

  19. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368–378.

    Article  PubMed  CAS  Google Scholar 

  20. Curvers WL, Ten Kate FJ, Krishnadath KK, Visser M, Elzer B, Baak LC, et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol 2010;105:1523–1530.

    Article  PubMed  Google Scholar 

  21. Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, Wang KK, Fleischer DE, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 2011;141:460–468.

    Article  PubMed  Google Scholar 

  22. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008;67:394–398.

    Article  PubMed  Google Scholar 

  23. Seewald S, Akaraviputh T, Seitz U, Brand B, Groth S, Mendoza G, et al. Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003;57:854–859.

    Article  PubMed  Google Scholar 

  24. Inoue H, Sato Y, Sugaya S, Inui M, Odaka N, Satodate H, et al. Endoscopic mucosal resection for early-stage gastrointestinal cancers. Best Pract Res Clin Gastroenterol 2005;19:871–887.

    Article  PubMed  Google Scholar 

  25. Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N. Endoscopic mucosal resection. Gastrointest Endosc 2003;57:567–579.

    Article  PubMed  Google Scholar 

  26. Giovannini M, Bories E, Pesenti C, Moutardier V, Monges G, Danisi C, et al. Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 2004;36:782–787.

    Article  PubMed  CAS  Google Scholar 

  27. Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 2007;65:3–10.

    Article  PubMed  Google Scholar 

  28. Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008;68:867–876.

    Article  PubMed  Google Scholar 

  29. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s esophagus. Gut 2008;57:1200–1206.

    Article  PubMed  CAS  Google Scholar 

  30. Van Den Eynde M, Jouret-Mourin A, Sempoux C, Piessevaux H, Deprez PH. Endoscopic mucosal or submucosal resection of early neoplasia in Barrett’s esophagus after antirefluxsurgery. Gastrointest Endosc 2010;72:855–861.

    Article  Google Scholar 

  31. Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I. Endoscopic ablation of dysplastic Barrett’s esophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and costeffectiveness. Scand J Gastroenterol 2005;40:750–758.

    Article  PubMed  Google Scholar 

  32. Sharma P, Wani S, Weston AP, Bansal A, Hall M, Mathur S, et al. A randomised controlled trial of ablation of Barrett’s esophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long-term results. Gut 2006;55:1233–1239.

    Article  PubMed  CAS  Google Scholar 

  33. Bright T, Watson DI, Tam W, Game PA, Astill D, Ackroyd R, et al. Randomized trial of argon plasma coagulation versus endoscopic surveillance for Barrett esophagus after antireflux surgery: late results. Ann Surg 2007;246:1016–1020.

    Article  PubMed  Google Scholar 

  34. Bronner MP, Overholt BF, Taylor SL, Game PA, Astill D, Ackroyd R, et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett’s esophagus with highgrade dysplasia. Gastroenterology 2009;136:56–64

    Article  PubMed  Google Scholar 

  35. Peters F, Kara M, Rosmolen W, Aalders M, Ten Kate F, Krishnadath K, et al. Poor results of 5-aminolevulinic acid photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett esophagus after endoscopic resection. Endoscopy 2005;37:418–424.

    Article  PubMed  CAS  Google Scholar 

  36. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc 2007;66:460–468.

    Article  PubMed  Google Scholar 

  37. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009;360:2277–2288.

    Article  PubMed  CAS  Google Scholar 

  38. Shaheen NJ, Peery AF, Overholt BF, Lightdale CJ, Chak A, Wang KK, et al. Biopsy depth after radiofrequency ablation of dysplastic Barrett’s esophagus. Gastrointest Endosc 2010;72:490–496.

    Article  PubMed  Google Scholar 

  39. Shaheen NJ, Greenwald BD, Peery AF, Dumot JA, Nishioka NS, Wolfsen HC, et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc 2010;71:680–685.

    Article  PubMed  Google Scholar 

  40. Pouw RE, van Vilsteren FG, Peters FP, Herrero LA, Ten Kate FJ, Visser M, et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 2011;74:35–43.

    Article  PubMed  Google Scholar 

  41. van Vilsteren FG, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s esophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011;60:765–773.

    Article  PubMed  Google Scholar 

  42. Herrero LA, van Vilsteren FG, Pouw RE, Ten Kate FJ, Visser M, Seldenrijk CA, et al. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 2011;73:682–690.

    Article  PubMed  Google Scholar 

  43. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012;143:336–346.

    Article  PubMed  Google Scholar 

  44. Westerterp M, Koppert LB, Buskens CJ, Harrison R, Odze R, Vieth M, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005;446:497–504.

    Article  PubMed  Google Scholar 

  45. Gilbert EW, Luna RA, Harrison VL, Hunter JG. Barrett’s esophagus: a review of the literature. J Gastrointest Surg 2011;15:708–718.

    Article  PubMed  Google Scholar 

  46. Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008;85:424–429.

    Article  PubMed  Google Scholar 

  47. Perry KA, Enestvedt CK, Pham T, Welker M, Jobe BA, Hunter JG, et al. Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage I esophageal adenocarcinoma. Arch Surg 2009;144:679–684.

    Article  PubMed  Google Scholar 

  48. Verhage RJJ, Hazebroek EJ, Boone J, van Hillegersberg R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir 2009;64:135–146.

    PubMed  CAS  Google Scholar 

  49. Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, Ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004;60:703–710.

    Article  PubMed  Google Scholar 

  50. Das A, Singh V, Fleischer DE, Sharma VK. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008;103:1340–1345.

    Article  PubMed  Google Scholar 

  51. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931–968.

    Article  PubMed  CAS  Google Scholar 

  52. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50:368–372.

    Article  PubMed  CAS  Google Scholar 

  53. Thomas T, Abrams KR, De Caestecker JS, Robinson RJ. Meta analysis: Cancer risk in Barrett’s esophagus. Aliment Pharmacol Ther 2007;26:1465–1477.

    Article  PubMed  CAS  Google Scholar 

  54. Chang JY, Talley NJ, Locke GR 3rd, Katzka DA, Schleck CD, Zinsmeister AR, et al. Population screening for Barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc 2011;86:1174–1180.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut des maladies de l’appareil digestif, CHU de Nantes, 1, place Alexis-Ricordeau, F-44035, Nantes, France

    E. Coron & N. Musquer

Authors
  1. E. Coron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Musquer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Coron.

Additional information

Cet article a déjà été publié sous la référence: Musquer N, Coron E. Post’U FMC-HGE. Springer 2013;271–80.

About this article

Cite this article

Coron, E., Musquer, N. Endobrachyœsophage (EBO): surveillance et indications thérapeutiques. Acta Endosc 43, 266–274 (2013). https://doi.org/10.1007/s10190-013-0338-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10190-013-0338-9

Search

Navigation